Literature DB >> 3509138

Binding of basic drugs to rat lung mitochondria.

R Hori1, K Okumura, H Yoshida.   

Abstract

The role of the mitochondria in the accumulation of basic amine drugs in the rat lung was studied. Drug binding to the mitochondria was rapid and reached maximum levels after 2.5 min of incubation. Lipophilic basic drugs accumulated in the mitochondria more than nonlipophilic basic drugs and nonbasic drugs, and the accumulation was dose dependent. Schatchard plots revealed at least two independent sets of binding sites for basic drugs in the mitochondria. The binding was competitively inhibited by other basic drugs but not nonbasic drugs. The degree of inhibition by competing basic drugs was correlated with their lipid solubilities. These findings with isolated mitochondria agree with previous results obtained with the perfused lung preparation and indicate that the mitochondria play an important role in the accumulation of basic drugs in the lung.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3509138     DOI: 10.1023/a:1016423220624

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

Review 1.  Uptake, release and metabolism of drugs in the lungs.

Authors:  A Junod
Journal:  Pharmacol Ther B       Date:  1976

2.  The estimation of basic organic compounds in biological material; estimation of fluorescent compounds.

Authors:  B B BRODIE; S UDENFRIEND
Journal:  J Biol Chem       Date:  1947-04       Impact factor: 5.157

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  The fluorimetric estimation of N1-methylnicotinamide and its differentiation from coenzyme.

Authors:  K J CARPENTER; E KODICEK
Journal:  Biochem J       Date:  1950-04       Impact factor: 3.857

5.  Binding of propranolol and chlorpromazine by mitochondrial membranes.

Authors:  A Huunan-Seppälä
Journal:  Acta Chem Scand       Date:  1972

6.  Tissue distribution and metabolism of drugs. IV. Accumulation and penetration of some antibiotics in rat lungs.

Authors:  R Hori; H Yoshida; K Okumura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1979-06       Impact factor: 1.645

Review 7.  THe localization, metabolism and effects of drugs and toxicants in lung.

Authors:  E A Brown
Journal:  Drug Metab Rev       Date:  1974       Impact factor: 4.518

8.  Chlorphentermine binding in rat lung subcellular fractions and its displacement by desmethylimipramine.

Authors:  R F Minchin; K F Ilett; B W Madsen
Journal:  Biochem Pharmacol       Date:  1979-08-01       Impact factor: 5.858

9.  Studies on the uptake and binding of propranolol by rat tissues.

Authors:  D W Schneck; J F Pritchard; A H Hayes
Journal:  J Pharmacol Exp Ther       Date:  1977-12       Impact factor: 4.030

10.  Prostaglandin E1 uptake by isolated cat lungs perfused with physiological salt solution.

Authors:  J H Linehan; C A Dawson; V M Wagner-Weber
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-02
View more
  5 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Contribution of monoamine oxidase(MAO) to the binding of tertiary basic drugs in isolated perfused rat lung.

Authors:  H Yoshida; K Okumura; R Hori
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

3.  Binding of bepridil to isolated rat heart mitochondria.

Authors:  J M Schneider; A Younes
Journal:  Basic Res Cardiol       Date:  1989 Nov-Dec       Impact factor: 17.165

4.  Contribution of monoamine oxidase (MAO) to the binding of tertiary basic drugs in lung mitochondria.

Authors:  H Yoshida; A Kamiya; K Okumura; R Hori
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

5.  Contribution of lysosomes to the subcellular distribution of basic drugs in the rat liver.

Authors:  J Ishizaki; K Yokogawa; M Hirano; E Nakashima; Y Sai; S Ohkuma; T Ohshima; F Ichimura
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.